LICENSE AGREEMENTLicense Agreement • November 5th, 2019 • Chimerix Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2019 Company Industry JurisdictionTHIS LICENSE AGREEMENT (“Agreement”), effective as of September 30, 2019 (the “Effective Date”), is made by and between CHIMERIX, INC., a corporation organized and existing under the laws of the State of Delaware (“Chimerix”), and SYMBIO PHARMACEUTICALS LIMITED, a corporation organized and existing under the laws of Japan (“SymBio”).
SUPPLY AGREEMENTSupply Agreement • November 5th, 2019 • Chimerix Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2019 Company Industry JurisdictionThis SUPPLY AGREEMENT (this "Agreement") is made and entered into as of October 5, 2015 ("Effective Date"), by and between CANTEX Pharmaceuticals, Inc. formerly known as PARINGENIX, INC., a Delaware corporation ("Cantex") and SCIENTIFIC PROTEIN LABORATORIES LLC, a Delaware limited liability company ("SPL").
ContractLicense and Development Agreement • November 5th, 2019 • Chimerix Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2019 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.